Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > The Long Awaited Week

<< Previous

Bullboard Posts

Next >>

Post by longterm56on Jul 14, 2020 7:03pm

240 Views

Post# 31268005

The Long Awaited Week

All THTX shareholders [and potential shareholders]:

The long awaited duo of earnings call & AGM is finally here! Yes, we have gone through numerous "long awaited events" before and have become a bit cynical of "catalysts". But ... there is enough difference in tomorrow and Thursday's events that I am still able to build substantial expectations. Hopefully they will not be smothered with reality.

-LT

<< Previous

Bullboard Posts

Next >>

UniDoc brings AI-powered H3 Health Cube to Italy